Endolytix Technology, Inc. — Form D/A

Endolytix Technology, Inc. of BEVERLY, MA, a company, filed a Form D amendment with the SEC on 2023-09-13. The offering totals $4.3M, of which $4.3M was reported sold. Industry: Pharmaceuticals.

Offering

Issuer

Officers, directors & promoters (19)

NameRoleLocation
Rouxi HuDirectorBeverly, MA
Westly NolinDirectorBeverly, MA
Rouxi HuExecutive OfficerBeverly, MA
Westly NolinExecutive OfficerBeverly, MA
Ruoxi HuDirectorBeverly, MA
Ruoxi HuExecutive OfficerBeverly, MA
Westley NolinDirectorBeverly, MA
Westley NolinExecutive OfficerBeverly, MA
Richard SnyderDirectorBeverly, MA
Ron ZwanzigerDirectorBOSTON, MA
Ron ZwanzigerExecutive OfficerBOSTON, MA
Ron ZwanzigerPromoterBOSTON, MA
Gabrielle BernsteinExecutive OfficerBeverly, MA
John PattersonExecutive OfficerBeverly, MA
Gary MagnantDirectorNatick, MA
Gary MagnantExecutive OfficerNatick, MA
Gary MagnantPromoterNatick, MA
Jason HolderDirectorBeverly, MA
Jason HolderPromoterBeverly, MA

Other filings by this issuer (3)

FiledFormOfferingSold
2024-08-08D$8.0M$5.0M
2023-07-27D$4.3M$2.0M
2021-03-26D$12.0M$12.0M

More